>> And anyway, we\'ve little or no idea of what else trainers in previous generations were giving their horses.
Sure we do. Cocaine, morphine, heroin (that\'s why it\'s called \"horse\"), amphetamines, caffine, arsenic, collodial silver, digitalis ... whatever was
available at the corner pharmacists for humans, horses were given it, too, if the trainer was so inclined.
The concept of athletes - human, equine, dogs, whatever - running drug-free is relatively new.
It\'s interesting to read the Wikipedia (i.e.: any loon can author) entry on stanozolol use in humans, but I\'d not choose Wikipedia as a reliable primary reference for drug education.
I would also point out drugs commonly do not act the same in different species.
And, to reiterate a point that is nearly always completely ignored when lay people talk about pharmacology, there is a vast difference between the pharmacologic effects seen with \"proper use\", and the effects seen with \"abuse\".
A drug can be a miracle when used appropriately, and a killer when abused.
If there is abuse, you stop the abuse - you don\'t eliminate the drug and withhold it from those that need it or from proper use
By the way, Winstrol is no way comparable to EPO regarding red blood cell production, I don\'t care how much of it you give to a horse or dog.
So in the interest of higher accuracy, here\'s part of the veterinary drug insert for stanozolol. Much non-applicable is deleted, and the highlights are mine.
--------------
Stanozolol
Prescriber Highlights
Anabolic steroid
Contraindications: pregnant animals, breeding stallions, food animals. Extreme caution: cats, hepatic dysfunction, hypercalcemia, history of myocardial infarction, pituitary insufficiency, prostate carcinoma, mammary carcinoma, benign prostatic hypertrophy and during the nephrotic stage of nephritis. Caution: cardiac and renal dysfunction with enhanced fluid and electrolyte monitoring.
Adverse Effects: Potentially high incidence of hepatotoxicity in cats. Other possible effects: sodium, calcium, potassium, water, chloride, and phosphate retention; hepatotoxicity, behavioral (androgenic) changes and reproductive abnormalities (oligospermia, estrus suppression)
Category \"X\" for pregnancy; teratogenicity outweighs any possible benefit
Controlled substance in the USA
Drug Interactions; lab interactions
Pharmacology
Stanozolol possess the actions of other anabolic agents. It may be less androgenic than other anabolics that are routinely used in veterinary medicine, however. Refer to the discussion in the boldenone monograph for more information.
Uses/Indications
Labeled indications for the stanozolol product Winstrol®-V (Winthrop/Upjohn) include \"... to improve appetite, promote weight gain, and increase strength and vitality...\" in dogs, cats and horses. The manufacturer also states that: \"Anabolic therapy is intended primarily as an adjunct to other specific and supportive therapy, including nutritional therapy.\"
Like nandrolone, stanozolol has been used to treat anemia of chronic disease. Because stanozolol has been demonstrated to enhance fibrinolysis after parenteral injection, it may be efficacious in the treatment of feline aortic thromboembolism or in the treatment of thrombosis in nephrotic syndrome. However, at present, clinical studies and/or experience are apparently lacking for this indication.
Pharmacokinetics
No specific information was located for this agent. It is generally recommended that the injectable suspension be dosed on a weekly basis in both small animals and horses.
Contraindications/Precautions
Stanozolol is contraindicated in pregnant animals and in breeding stallions and should not be administered to horses intended for food purposes. Because of reported hepatotoxicity associated with this drug in cats, it should be used in this species with extreme caution.
The manufacturer recommends using stanozolol cautiously in patients with cardiac and renal dysfunction and with enhanced fluid and electrolyte monitoring.
In humans, anabolic agents are also contraindicated in patients with hepatic dysfunction, hypercalcemia, patients with a history of myocardial infarction (can cause hypercholesterolemia), pituitary insufficiency, prostate carcinoma, in selected patients with breast carcinoma, benign prostatic hypertrophy and during the nephrotic stage of nephritis.
Adverse Effects/Warnings
The manufacturer (Winthrop/Upjohn) lists as adverse effects in dogs, cats and horses only \"mild androgenic effects\" and then only when used with excessively high doses for a prolonged period of time.
[Note: the above is true in practice, too]
One study in cats, demonstrated a very high incidence of hepatotoxicity associated with stanozolol use and the authors recommended that this drug not be used in cats until further toxicological studies are performed.
Potentially (from human data), adverse reactions of the anabolic agents in dogs and cats could include: sodium, calcium, potassium, water, chloride, and phosphate retention, hepatotoxicity, behavioral (androgenic) changes and reproductive abnormalities (oligospermia, estrus suppression).
Overdosage
No information was located for this specific agent. In humans, sodium and water retention can occur after overdosage of anabolic steroids. It is suggested to treat supportively and monitor liver function should an inadvertent overdose be administered.
Drug Interactions
Anabolic agents as a class may potentiate the effects of anticoagulants. Monitoring of PT\'s and dosage adjustment, if necessary of the anticoagulant are recommended.
Diabetic patients receiving insulin may need dosage adjustments if anabolic therapy is added or discontinued. Anabolics may decrease blood glucose and decrease insulin requirements.
Anabolics may enhance the edema that can be associated with ACTH or adrenal steroid therapy.
Drug/Laboratory Interactions
Concentrations of protein bound iodine (PBI) can be decreased in patients receiving androgen/anabolic therapy, but the clinical significance of this is probably not important. Androgen/anabolic agents can decrease amounts of thyroxine-binding globulin and decrease total T4 concentrations and increase resin uptake of T3 and T4. Free thyroid hormones are unaltered and, clinically, there is no evidence of dysfunction.
Both creatinine and creatine excretion can be decreased by anabolic steroids. Anabolic steroids can increase the urinary excretion of 17-ketosteroids.
Androgenic/anabolic steroids may alter blood glucose levels. Androgenic/anabolic steroids may suppress clotting factors II, V, VII, and X. Anabolic agents can affect liver function tests (BSP retention, SGOT, SGPT, bilirubin, and alkaline phosphatase).
Doses
Dogs
For anemia secondary to chronic renal failure:
2. For anemias secondary to uremia:
As an anabolic/appetite stimulant:
For canine cognitive dysfunction:
Cats: Note: See Warnings Above
As an anabolic agent per labeled indications:
Treatment should continue for several weeks, depending on response and condition of animal. (Package Insert; Winstrol®-V --Winthrop/Upjohn)
Ferrets
Rabbits/Rodents/Pocket Pets
1. Rabbits: As an appetite stimulant: (Ivey and Morrisey 2000)
Horses
As an anabolic agent per labeled indications:
May repeat weekly for up to and including 4 weeks. (Package Insert; Winstrol®-V --Winthrop/Upjohn)
Sheep, Goats
For acute or subacute aflatoxicosis in ruminants:
Do not combine with oxytetracycline therapy. (Hatch 1988)
Birds
As an anabolic agent to promote weight gain and recovery from disease:
Reptiles
1. For most species post-surgically and in very debilitated animals:
Monitoring Parameters
----------------
1) Androgenic side effects; 2) Fluid and electrolyte status, if indicated; 3) Liver function tests if indicated; 4) RBC count, indices, if indicated; 5) Weight, appetite